AngioDynamics Stock Price, News & Analysis (NASDAQ:ANGO)

$19.25
+0.54 (+2.89 %)
(As of 09/20/2019 04:00 PM ET)
Today's Range
$18.72
Now: $19.25
$19.30
50-Day Range
$17.76
MA: $18.84
$20.37
52-Week Range
$17.67
Now: $19.25
$25.48
Volume290,105 shs
Average Volume160,740 shs
Market Capitalization$720.91 million
P/E Ratio23.19
Dividend YieldN/A
Beta0.72
AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ANGO
CUSIP03475V10
Phone518-795-1400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$359.48 million
Cash Flow$1.6028 per share
Book Value$16.52 per share

Profitability

Net Income$61.34 million

Miscellaneous

Employees1,050
Market Cap$720.91 million
Next Earnings Date10/3/2019 (Confirmed)
OptionableOptionable

Receive ANGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter.


AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) announced its quarterly earnings data on Wednesday, July, 10th. The medical instruments supplier reported $0.25 EPS for the quarter, missing the Zacks' consensus estimate of $0.26 by $0.01. The medical instruments supplier had revenue of $96.30 million for the quarter, compared to analyst estimates of $92.34 million. AngioDynamics had a return on equity of 5.58% and a net margin of 17.06%. The business's quarterly revenue was up 9.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.20 earnings per share. View AngioDynamics' Earnings History.

When is AngioDynamics' next earnings date?

AngioDynamics is scheduled to release their next quarterly earnings announcement on Thursday, October 3rd 2019. View Earnings Estimates for AngioDynamics.

How can I listen to AngioDynamics' earnings call?

AngioDynamics will be holding an earnings conference call on Thursday, October 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY20 earnings guidance on Wednesday, July, 10th. The company provided EPS guidance of $0.25-0.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.26. The company issued revenue guidance of $280-286 million, compared to the consensus revenue estimate of $280.90 million.

What price target have analysts set for ANGO?

1 brokerages have issued 12-month price targets for AngioDynamics' stock. Their predictions range from $23.00 to $23.00. On average, they expect AngioDynamics' share price to reach $23.00 in the next year. This suggests a possible upside of 19.5% from the stock's current price. View Analyst Price Targets for AngioDynamics.

What is the consensus analysts' recommendation for AngioDynamics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for AngioDynamics.

Has AngioDynamics been receiving favorable news coverage?

News coverage about ANGO stock has been trending somewhat negative on Saturday, according to InfoTrie. The research firm scores the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. AngioDynamics earned a news sentiment score of -1.3 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for AngioDynamics.

Are investors shorting AngioDynamics?

AngioDynamics saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 1,409,300 shares, an increase of 10.2% from the July 31st total of 1,279,100 shares. Based on an average daily volume of 195,700 shares, the short-interest ratio is presently 7.2 days. Currently, 3.9% of the shares of the stock are sold short. View AngioDynamics' Current Options Chain.

Who are some of AngioDynamics' key competitors?

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include Oasis Petroleum (OAS), General Electric (GE), Intel (INTC), Mattel (MAT), Chesapeake Energy (CHK), Centurylink (CTL), DIGITAL RLTY TR/SH (DLR), Hanesbrands (HBI), Kimco Realty (KIM) and Regions Financial (RF).

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the folowing people:
  • Mr. James C. Clemmer, CEO, Pres & Director (Age 55)
  • Mr. Michael C. Greiner, Exec. VP & CFO (Age 46)
  • Mr. David D. Helsel, Sr. VP of Global Operations and R&D (Age 55)
  • Mr. Stephen A. Trowbridge, Sr. VP & Gen. Counsel (Age 45)
  • Mr. Robert A. Simpson, Sr. VP & GM of Vascular Interventions and Therapies (Age 47)

Who are AngioDynamics' major shareholders?

AngioDynamics' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.72%), Victory Capital Management Inc. (10.12%), Vanguard Group Inc. (6.16%), Janus Henderson Group PLC (3.28%), Janus Henderson Group PLC (3.28%) and Northern Trust Corp (3.16%). Company insiders that own AngioDynamics stock include Kevin J Gould and Michael Greiner. View Institutional Ownership Trends for AngioDynamics.

Which major investors are selling AngioDynamics stock?

ANGO stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, JPMorgan Chase & Co., THB Asset Management, Renaissance Technologies LLC, Invesco Ltd., AXA, Janus Henderson Group PLC and Janus Henderson Group PLC. Company insiders that have sold AngioDynamics company stock in the last year include Kevin J Gould and Michael Greiner. View Insider Buying and Selling for AngioDynamics.

Which major investors are buying AngioDynamics stock?

ANGO stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Systematic Financial Management LP, Nuveen Asset Management LLC, Price T Rowe Associates Inc. MD, Marshall Wace North America L.P., BlackRock Inc., Morgan Stanley and Natixis Advisors L.P.. View Insider Buying and Selling for AngioDynamics.

How do I buy shares of AngioDynamics?

Shares of ANGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $19.25.

How big of a company is AngioDynamics?

AngioDynamics has a market capitalization of $720.91 million and generates $359.48 million in revenue each year. The medical instruments supplier earns $61.34 million in net income (profit) each year or $0.83 on an earnings per share basis. AngioDynamics employs 1,050 workers across the globe.View Additional Information About AngioDynamics.

What is AngioDynamics' official website?

The official website for AngioDynamics is http://www.angiodynamics.com/.

How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected]


MarketBeat Community Rating for AngioDynamics (NASDAQ ANGO)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  301 (Vote Outperform)
Underperform Votes:  372 (Vote Underperform)
Total Votes:  673
MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe ANGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2019 by MarketBeat.com Staff

Featured Article: Market Perform

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel